June 20, 2023 Intelligent Bio Solutions Receives Non-Dilutive Grant Funding of USD $1.43 Million May 24, 2023 Intelligent Bio Solutions to Participate in the LD Micro Invitational XIII on June 6th May 16, 2023 Intelligent Bio Solutions Plans to Add Fentanyl Testing as it Further Enhances its Fingerprint-Based Drug Screening Solution May 11, 2023 Intelligent Bio Solutions Inc. Reports Fiscal 2023 Third Quarter Financial Results and Operational Highlights May 2, 2023 Intelligent Bio Solutions Scales Reach Throughout Asia-Pacific Region with Addition of Sales Team in Australia, New Distribution Hub and Office Facility April 26, 2023 UK Food Processing Equipment Manufacturer Latest to Adopt Intelligent Bio Solutions’ Portable Fingerprint Drug Testing Solution April 18, 2023 Intelligent Bio Solutions Secures UK Patent for Intelligent Fingerprinting DSR-Plus Cartridge Reader March 27, 2023 A & F Sprinklers Selects Intelligent Bio Solutions’ Latest DSR-Plus Screening Unit to Support its Random Drug Screening Program March 13, 2023 Intelligent Bio Solutions Inc. Selects HASTA Laboratory as Drug Testing Specialist in Australia March 10, 2023 Intelligent Bio Solutions Inc. Announces Closing of $2.55 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares and Warrants
May 16, 2023 Intelligent Bio Solutions Plans to Add Fentanyl Testing as it Further Enhances its Fingerprint-Based Drug Screening Solution
May 11, 2023 Intelligent Bio Solutions Inc. Reports Fiscal 2023 Third Quarter Financial Results and Operational Highlights
May 2, 2023 Intelligent Bio Solutions Scales Reach Throughout Asia-Pacific Region with Addition of Sales Team in Australia, New Distribution Hub and Office Facility
April 26, 2023 UK Food Processing Equipment Manufacturer Latest to Adopt Intelligent Bio Solutions’ Portable Fingerprint Drug Testing Solution
April 18, 2023 Intelligent Bio Solutions Secures UK Patent for Intelligent Fingerprinting DSR-Plus Cartridge Reader
March 27, 2023 A & F Sprinklers Selects Intelligent Bio Solutions’ Latest DSR-Plus Screening Unit to Support its Random Drug Screening Program
March 13, 2023 Intelligent Bio Solutions Inc. Selects HASTA Laboratory as Drug Testing Specialist in Australia
March 10, 2023 Intelligent Bio Solutions Inc. Announces Closing of $2.55 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares and Warrants
